Reproductive burden in women with central hypersomnolence disorders: a cross-sectional survey.
Sleep Medicine · 2026-11 · 109348
DOI: 10.1016/j.sleep.2026.109348 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Sleep Medicine, 2026-11. Verfasst von Hinatea Houziaux und 4 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP, Hôtel-Dieu, Centre Du Sommeil et de La Vigilance, Centre de Référence Narcolepsies et Hypersomnies Rares, Paris, France. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Women with narcolepsy or idiopathic hypersomnia face specific challenges in their reproductive lives, due to, (1) the potential teratogenic effect of several commonly prescribed therapies, (2) the reduced efficacy of oral hormonal contraceptives with some agents, and (3) treatment discontinuation during pregnancy, which often impairs daily functioning. This study aims at evaluating those challenges. METHODS: An 11-item survey was distributed to 91 women diagnosed with narcolepsy or idiopathic hypersomnia in one reference center. The first section covered diagnosis, treatments, and contraception. A second section addressed pregnancy history and outcomes. Finally, the patients were asked to assess the impact of their disorder on domains related to reproductive health and womanhood. RESULTS: Responses from 91 women diagnosed with narcolepsy type 1, narcolepsy type 2 or idiopathic hypersomnia were analyzed. 84,6% of patients received an enzyme-inducing treatment as first-line therapy, although most (68.1%) were already using oral hormonal contraception at treatment initiation. Consequently, 42 (45.1%) changed their contraceptive method. 22 (24.2%) reported a pregnancy after diagnosis and provided pregnancy-related outcomes. Communication with primary care professionals was rated as difficult, with many respondents reporting challenges obtaining clear guidance. On a scale from 0 to 10, the negative effect of the disease on women-specific aspects of their life was 5.56/10. CONCLUSION: Narcolepsy and idiopathic hypersomnia are rare diseases that are usually under-recognized among non-specialists. Women report unmet needs regarding their condition and its treatment. Structured therapeutic education programs should be implemented to support decision-making around medications, contraception, pregnancy planning, and perinatal care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AP-HP, Hôtel-Dieu, Centre Du Sommeil et de La Vigilance, Centre de Référence Narcolepsies et Hypersomnies Rares, Paris, France.
- AP-HP, Hôtel-Dieu, Centre Du Sommeil et de La Vigilance, Centre de Référence Narcolepsies et Hypersomnies Rares, Paris, France; Université Paris Cité, VIFASOM UMR, Paris, France.
- AP-HP, Hôtel-Dieu, Centre Du Sommeil et de La Vigilance, Centre de Référence Narcolepsies et Hypersomnies Rares, Paris, France; Université Paris Cité, VIFASOM UMR, Paris, France; Maternité des Bluets, Service de Procréa…
Zitieren
APA
Houziaux, H., Gauriau, C., Labonne, A., Léger, D., & Rouen, A. (2026). Reproductive burden in women with central hypersomnolence disorders: a cross-sectional survey. Sleep Medicine, 109348. https://doi.org/10.1016/j.sleep.2026.109348
Vancouver
Houziaux H, Gauriau C, Labonne A, Léger D, Rouen A. Reproductive burden in women with central hypersomnolence disorders: a cross-sectional survey. Sleep Medicine. 2026:109348. doi:10.1016/j.sleep.2026.109348
BibTeX
@article{Houziaux2026,
author = {Houziaux, Hinatea and Gauriau, Caroline and Labonne, Annabelle and Léger, Damien and Rouen, Alexandre},
title = {Reproductive burden in women with central hypersomnolence disorders: a cross-sectional survey},
journal = {Sleep Medicine},
year = {2026},
pages = {109348},
doi = {10.1016/j.sleep.2026.109348}
}
EUVIMED